secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2021-08-26T23:59:59+00:00
Accession:  0001104659-21-109522
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio appoints William D. Clark to board of directors
----------------------------------------------------

- William D. Clark elected as Class III Director, effective August 23, 2021.
- Clark has 30+ years biotech/pharma experience, currently CEO of Genocea Biosciences.
- He receives $40k annual cash retainer, additional fees for Audit and Nominating committees, and a 100k-share stock option.
- Clark will serve on Audit Committee and Nominating and Corporate Governance Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000110465921109522/0001104659-21-109522-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000110465921109522/tm2125952d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-109522

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer